These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models. Chan CH; Mitchison HM; Pearce DA Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598 [TBL] [Abstract][Full Text] [Related]
4. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex. Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045 [TBL] [Abstract][Full Text] [Related]
5. CLN3 is required for the clearance of glycerophosphodiesters from lysosomes. Laqtom NN; Dong W; Medoh UN; Cangelosi AL; Dharamdasani V; Chan SH; Kunchok T; Lewis CA; Heinze I; Tang R; Grimm C; Dang Do AN; Porter FD; Ori A; Sabatini DM; Abu-Remaileh M Nature; 2022 Sep; 609(7929):1005-1011. PubMed ID: 36131016 [TBL] [Abstract][Full Text] [Related]
6. Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers. Sleat DE; Tannous A; Sohar I; Wiseman JA; Zheng H; Qian M; Zhao C; Xin W; Barone R; Sims KB; Moore DF; Lobel P J Proteome Res; 2017 Oct; 16(10):3787-3804. PubMed ID: 28792770 [TBL] [Abstract][Full Text] [Related]
7. Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity. Cárcel-Trullols J; Kovács AD; Pearce DA J Cell Biochem; 2017 Nov; 118(11):3883-3890. PubMed ID: 28390177 [TBL] [Abstract][Full Text] [Related]
8. The CLN3 gene and protein: What we know. Mirza M; Vainshtein A; DiRonza A; Chandrachud U; Haslett LJ; Palmieri M; Storch S; Groh J; Dobzinski N; Napolitano G; Schmidtke C; Kerkovich DM Mol Genet Genomic Med; 2019 Dec; 7(12):e859. PubMed ID: 31568712 [TBL] [Abstract][Full Text] [Related]
9. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Luiro K; Yliannala K; Ahtiainen L; Maunu H; Järvelä I; Kyttälä A; Jalanko A Hum Mol Genet; 2004 Dec; 13(23):3017-27. PubMed ID: 15471887 [TBL] [Abstract][Full Text] [Related]
10. Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach. Scifo E; Szwajda A; Dębski J; Uusi-Rauva K; Kesti T; Dadlez M; Gingras AC; Tyynelä J; Baumann MH; Jalanko A; Lalowski M J Proteome Res; 2013 May; 12(5):2101-15. PubMed ID: 23464991 [TBL] [Abstract][Full Text] [Related]
11. Defective lysosomal arginine transport in juvenile Batten disease. Ramirez-Montealegre D; Pearce DA Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady. Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751 [TBL] [Abstract][Full Text] [Related]
13. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis. Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292 [TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease. Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3). Burkovetskaya M; Karpuk N; Kielian T Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098 [TBL] [Abstract][Full Text] [Related]
16. A mouse mutant deficient in both neuronal ceroid lipofuscinosis-associated proteins CLN3 and TPP1. Sleat DE; Banach-Petrosky W; Larrimore KE; Nemtsova Y; Wiseman JA; Najafi A; Johnson D; Poole TA; Takahashi K; Cooper JD; Lobel P J Inherit Metab Dis; 2023 Jul; 46(4):720-734. PubMed ID: 37078466 [TBL] [Abstract][Full Text] [Related]
17. Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation. Calcagni' A; Staiano L; Zampelli N; Minopoli N; Herz NJ; Di Tullio G; Huynh T; Monfregola J; Esposito A; Cirillo C; Bajic A; Zahabiyon M; Curnock R; Polishchuk E; Parkitny L; Medina DL; Pastore N; Cullen PJ; Parenti G; De Matteis MA; Grumati P; Ballabio A Nat Commun; 2023 Jul; 14(1):3911. PubMed ID: 37400440 [TBL] [Abstract][Full Text] [Related]
18. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Luiro K; Kopra O; Lehtovirta M; Jalanko A Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129 [TBL] [Abstract][Full Text] [Related]
19. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease. Shematorova EK; Shpakovski GV Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890 [TBL] [Abstract][Full Text] [Related]
20. A novel in-frame mutation in Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110 [No Abstract] [Full Text] [Related] [Next] [New Search]